Location changes risk
A superficial non-eloquent lesion and a tumor near speech, movement, vision, brainstem, or major vessels require different planning.
Brain tumor treatment cost in Thailand
Brain tumor care is not one operation. The estimate may include MRI and functional mapping, biopsy or resection, navigation, neuromonitoring, pathology and molecular classification, ICU, radiation, chemotherapy, targeted treatment, seizure control, steroid taper, speech or movement rehabilitation, and repeated imaging. Thailand has tertiary neurosurgical and oncology services, but the patient should confirm the named surgeon, neuro-oncology team, pathology, ICU, rehabilitation, and an emergency plan before travel.
How much does brain tumor treatment cost in Thailand?
Diagnostic work and resection for a selected accessible tumor may be planned at THB 660,000 to 1,650,000, approximately USD 20,000 to 50,000. Surgery followed by radiation or chemotherapy may range from THB 1,320,000 to 3,300,000, around USD 40,000 to 100,000. Deep, recurrent, high-grade, eloquent-area, or complication-prone care can reach THB 2,310,000 to 6,600,000+, approximately USD 70,000 to 200,000+. These are planning ranges and depend on imaging, pathology, ICU, and the treatment sequence.
USD illustrations use approximately THB 33 per USD, based on the Bank of Thailand exchange-rate context checked in July 2026. Device, navigation, pathology, radiation, and medicine invoices may use another currency. Confirm deposit, exchange adjustment, ICU overstay, and final billing terms.
Share the basics and the Virello team will guide you toward the next step.
Prefer email? Write to support@virellohealth.com.
Reviewed 2026-07-19
Clinical review: Virello Health Clinical Content Team · Editorial review: Virello Health Research Team
Billing context: THB and USD
A superficial non-eloquent lesion and a tumor near speech, movement, vision, brainstem, or major vessels require different planning.
The aim may be diagnosis, decompression, maximal safe resection, or symptom relief when complete removal risks function.
Grade, molecular markers, and tissue diagnosis can determine radiation, chemotherapy, targeted therapy, or surveillance.
Weakness, seizures, swelling, ventilation, feeding, speech, movement, vision, and cognition can extend care.
Steroid dose and taper affect swelling, glucose, infection, sleep, muscle, and travel readiness.
Cost at a glance
The scenarios separate routine and complex pathways. They are not fixed packages and should be replaced by a report-led hospital estimate before travel.
| Scenario | THB | USD | Patient and treatment context | Planning scope |
|---|---|---|---|---|
| Biopsy or accessible resection | THB 660,000 - 1,650,000 | USD 20,000 - 50,000 | A lesion with a defined operative route, expected routine anesthesia and ICU course, and no planned combined skull-base or vascular procedure. | List MRI review, surgeon, anesthesia, navigation or monitoring, pathology, room, ICU, medicines, and early neurologic assessment. |
| Resection plus adjuvant care | THB 1,320,000 - 3,300,000 | USD 40,000 - 100,000 | A tumor requiring surgery followed by radiation, chemotherapy, targeted therapy, seizure management, and rehabilitation. | Separate pathology and molecular testing, radiation planning and fractions, medicines, scans, and home rehabilitation. |
| Complex or recurrent neuro-oncology | THB 2,310,000 - 6,600,000+ | USD 70,000 - 200,000+ | Deep or eloquent-area tumor, recurrence, major swelling, vascular involvement, repeat surgery, prolonged ICU, or serious neurologic deficit. | Use a scenario budget for ICU, ventilation, feeding, infection, rehabilitation, re-operation, and changing treatment response. |
Usually included
MRI review, neurological examination, operative discussion, anesthesia risk, seizure and steroid assessment, and informed consent.
Send complete source MRI and prior operation records.
Biopsy, craniotomy, endoscopic, skull-base, stereotactic, or resection approach with stated navigation and monitoring assumptions.
The phrase “tumor removal” is not enough.
Specimen processing, ICU and ward allowance, postoperative imaging, medicines, nursing, and neurologic review.
Molecular tests and ICU extension may be separate.
Radiation, chemotherapy, targeted treatment, seizure and steroid plan, rehabilitation, scan schedule, and home-team handover as quoted.
Long-term neurorehabilitation is usually separate.
Confirm separately
Functional MRI, tractography, PET, angiography, Wada or language testing, intraoperative mapping, and special monitoring unless listed.
Ask what is essential for this tumor location.
Ventilation, feeding tube, infection treatment, seizures, swelling, stroke, transfusion, dialysis, re-operation, and prolonged ICU.
Obtain daily rates for high-risk cases.
Radiation, chemotherapy, targeted drug, immunotherapy, repeated MRI, molecular testing, and clinical-trial assessment.
A surgical quote rarely includes these phases.
Speech, occupational, physical, cognitive, vision, neuropsychology, caregiver, hotel, transport, and delayed flight.
Budget recovery beyond discharge.
Candidate context
Brain tumor treatment depends on symptoms, MRI location, size, edema, hydrocephalus, suspected type, grade, molecular biology, accessibility, relationship to speech or movement pathways, seizures, general health, and the patient’s priorities. Observation can be reasonable for selected benign or slow-growing lesions. Biopsy may be safer than resection when diagnosis is the main need. Surgery may decompress or remove as much tumor as safely possible, followed by radiation, chemotherapy, targeted treatment, or surveillance. A Thai team should explain function risk and what happens if the tumor cannot be completely removed.
MRI pattern may suggest a tumor but tissue and molecular testing often determine grade and treatment; a biopsy route may be safer than open surgery.
Speech, movement, vision, memory, swallowing, cranial nerves, brainstem, deep nuclei, and major vessels influence surgical risk.
Heart, lungs, kidney, blood clotting, infection, nutrition, frailty, and steroid or seizure medicines affect anesthesia and recovery.
Final pathology, wound healing, neurologic function, radiation access, medicine supply, and the ability to attend follow-up guide the next phase.
Active seizures, raised pressure, uncontrolled vomiting, new weakness, altered consciousness, or a recent operation may make elective travel unsafe.
Selected small, slow-growing, asymptomatic, or benign-appearing lesions may be monitored with a defined review schedule.
A targeted sample can establish diagnosis when open removal carries unacceptable functional risk.
The goal may be to remove the greatest safe volume while protecting speech, movement, vision, cognition, and critical structures.
Radiation, chemotherapy, targeted medicine, immunotherapy, or palliative care may be primary or follow surgery according to pathology.
Procedure variations
Technique, device, medicine, treatment extent, and prior care can change both the clinical plan and the estimate.
An opening in the skull permits biopsy or tumor removal with navigation and possible monitoring.
Location, eloquence, blood vessels, and safe-removal goal should be stated.
A needle route obtains tissue from a deep or diffuse lesion when resection is not the safest first move.
Ask about nondiagnostic sample and repeat-procedure terms.
Selected lesions near the skull base or ventricular system may be approached through a smaller or endoscopic corridor.
Cranial-nerve, fluid-leak, and conversion risks remain.
Selected eloquent-area tumors may use language or movement mapping to protect function.
Mapping team, equipment, and rehabilitation should be itemized.
Radiation, temozolomide or another chemotherapy, targeted treatment, immune treatment, or surveillance follows pathology.
Price each phase after the final report.
City comparison
Only cities with evidence for the procedure should appear here. A city range does not prove that every hospital in that city can manage the same case complexity.
| City | Local range | USD range | Capability context | Stay planning |
|---|---|---|---|---|
| Bangkok | THB 825,000 - 6,600,000+ | USD 25,000 - 200,000+ | The broadest concentration of neurosurgery, neuro-oncology, radiation, molecular pathology, ICU, and rehabilitation. | Confirm the named surgeon, navigation, monitoring, ICU, and home rehab pathway. |
| Chiang Mai | THB 759,000 - 5,610,000+ | USD 23,000 - 170,000+ | University and private tertiary care may offer surgery and oncology for selected patients. | Ask about neuro-ICU, pathology, radiation, and transfer for complex cases. |
| Phuket | THB 792,000 - 5,280,000+ | USD 24,000 - 160,000+ | International coordination exists, while complex neuro-oncology depth varies by hospital. | Choose a tertiary neurosurgical service before planning accommodation. |
| Pattaya and Chon Buri | THB 759,000 - 4,950,000+ | USD 23,000 - 150,000+ | Eastern regional services may support selected planned neurosurgery or oncology. | Confirm ICU, neuromonitoring, radiation, and emergency transfer. |
| Khon Kaen | THB 726,000 - 4,620,000+ | USD 22,000 - 140,000+ | A northeastern tertiary pathway may suit stable, planned cases with a documented team. | Ask about molecular pathology and intensive rehabilitation. |
| Hat Yai and Songkhla | THB 726,000 - 4,620,000+ | USD 22,000 - 140,000+ | Southern regional care can be considered after reviewing lesion location and functional risk. | The hospital should explain rescue and referral arrangements. |
| Nakhon Ratchasima | THB 693,000 - 4,290,000+ | USD 21,000 - 130,000+ | Selected regional neurosurgery, pathology, and follow-up may offer value. | Verify navigation, monitoring, ICU, and radiation access. |
| Chiang Rai | THB 693,000 - 4,125,000+ | USD 21,000 - 125,000+ | Regional assessment is possible; complex skull-base or eloquent-area care may need referral. | Secure a documented escalation route before travel. |
| Udon Thani | THB 660,000 - 4,125,000+ | USD 20,000 - 125,000+ | Planned surgery or stable oncology follow-up can be feasible in selected centers. | Clarify language, rehabilitation, and MRI follow-up support. |
| Rayong | THB 693,000 - 4,455,000+ | USD 21,000 - 135,000+ | Eastern corridor access may help selected planned care. | Transport convenience cannot replace neuro-ICU capability. |
Estimate variables
Deep, brainstem, skull-base, vascular, ventricular, or eloquent-area disease changes planning, equipment, and functional risk.
The MRI should be reviewed by the operating surgeon.
Biopsy, frozen section, immunohistochemistry, methylation or molecular tests, and outside review guide treatment.
Ask whether the tissue is adequate.
Neuronavigation, tractography, mapping, intraoperative MRI, ultrasound, and neuromonitoring can add resources.
Equipment should be named, not implied.
Ventilation, seizures, swelling, stroke, infection, feeding, weakness, and confusion can extend the admission.
Get ICU and rehabilitation assumptions.
Radiation, chemotherapy, targeted therapy, repeat MRI, steroids, seizure medicines, and rehabilitation continue after surgery.
Separate the first admission from the full pathway.
Medical cost breakdown
Contrast MRI, perfusion, spectroscopy, tractography, functional MRI, spine imaging, or vascular studies when indicated.
Send original images and prior comparison studies.
Stereotactic biopsy, craniotomy sample, frozen section, histology, immunostains, and molecular classification.
A pathology quote should describe storage and review.
Neurological examination, seizure assessment, blood tests, ECG, anesthesia, endocrine or ophthalmic assessment, and rehabilitation baseline.
Emergency symptoms need local care first.
Anesthesia, craniotomy or biopsy, navigation, neuromonitoring, microscope or endoscope, theatre, and specimen handling.
Ask about conversion and extra equipment.
Ventilation, intracranial pressure observation, imaging, seizure and steroid medicines, nursing, drains, and neurologic checks.
Extra days can change the estimate quickly.
Radiation planning, oncology consultation, chemotherapy or targeted medicine preparation, and discharge coordination.
The full course is often outside the surgical package.
Speech, movement, balance, swallowing, cognition, vision, seizure control, wound, and steroid management.
A companion may need training.
MRI, blood counts, chemotherapy, targeted drugs, immune effects, steroid taper, and symptom review.
Home laboratory access should be arranged.
Physiotherapy, occupational, speech, cognitive, vision, nutrition, caregiver, accessible hotel, and transport.
Budget for a slower recovery.
Complete journey budget
Patient and attendant costs should be modeled separately from the medical estimate, with flexible dates and a contingency reserve.
MRI source data, pathology, seizures, steroids, symptoms, medicines, visa, insurance, companion, and hospital acceptance.
New weakness or reduced consciousness is urgent.
Admission, ICU, ward, rehabilitation, accessible housing, meals, transport, interpreter, and extra nights.
The patient may need a caregiver beyond discharge.
Fit-to-fly, seizure and steroid plan, MRI timing, oncology, rehabilitation, emergency route, and records handover.
Do not travel without a written neurologic plan.
Country access
Visa, donor, fertility, medicine, licensing, and treatment-access requirements can change. Confirm current rules with the relevant authority and treating hospital.
Use Thailand Medical Hub and hospital information to confirm the exact neurosurgical campus, ICU, radiation service, and international pathway.
Confirm navigation, mapping, monitoring, pathology, neuro-ICU, seizure care, and rehabilitation for the lesion’s location.
Verify radiation machine, physicist, chemotherapy or targeted medicine, molecular laboratory, and emergency toxicity support.
Agree pathology release, courier, consent, records translation, slide return, and cross-border data handling.
Check Thailand e-Visa or embassy guidance and allow for neurologic recovery, delayed discharge, and caregiver documentation.
Hospital selection
Tumor surgeon, skull-base or functional specialist when relevant, neuroanesthetist, neuro-ICU, and operating support.
Ask who will perform the procedure.
Frozen section, final histology, molecular tests, radiation, chemotherapy, targeted treatment, and clinical-trial assessment.
Final treatment depends on tissue.
Navigation, mapping, neuromonitoring, intraoperative imaging, speech or movement assessment, and postoperative MRI.
Match tools to lesion risk.
Speech, movement, cognition, swallowing, vision, seizure, nutrition, and caregiver education.
Recovery can outlast the hospital package.
Seizure, swelling, stroke, infection, bleeding, wound, steroid, scan, medicine, and emergency communication plans.
Obtain records before departure.
Treating team
Reviews the MRI, location, functional risk, operative corridor, safe-removal goal, monitoring, and complications.
Interpret pathology and design chemotherapy, targeted, immune, radiation, surveillance, and recurrence plans.
Clarify lesion behavior, stage, tissue diagnosis, molecular profile, treatment response, and imaging follow-up.
Manage airway, swelling, pressure, seizures, blood pressure, ventilation, infection, and early neurologic recovery.
Supports speech, movement, cognition, vision, swallowing, independence, caregiver training, and return travel.
Treatment timeline
Send contrast MRI source images, reports, symptoms, examination, seizures, steroids, prior pathology, and previous treatment.
The Thai team decides whether observation, biopsy, resection, mapping, radiation, or another route best balances diagnosis and function.
Biopsy or resection is performed with the agreed access, navigation, monitoring, ICU, pathology, and postoperative imaging.
Final diagnosis and molecular results determine radiation, chemotherapy, targeted therapy, immunotherapy, or surveillance.
Seizure, steroid, speech, strength, balance, swallowing, cognition, wound, and mobility are reviewed before leaving hospital.
The home team receives pathology, treatment summary, medicines, MRI schedule, warning signs, and rehabilitation instructions.
Risks and edge cases
A new deficit, repeated seizure, confusion, vomiting, or severe headache needs urgent assessment rather than elective travel.
Stabilize locally first.
Speech, movement, vision, swallowing, memory, or behavior can worsen temporarily or permanently after treatment.
Ask about rehabilitation and caregiver needs.
Steroids, ICU observation, repeat imaging, drainage, or re-operation may be required.
ICU and emergency terms should be written.
Dose adjustment, drug interaction, glucose disturbance, infection, insomnia, and withdrawal can affect recovery.
Never change these medicines without clinical advice.
A sample may be insufficient or show a different tumor type, changing surgery, radiation, and medicine.
Budget review and additional testing.
Weakness, poor balance, feeding needs, seizures, wound, or cognitive change may require a longer stay.
Use flexible travel and accessible housing.
Destination comparison
The most suitable destination depends on the individual case, required team, treatment availability, travel route, legal eligibility, budget, and continuity after returning home.
| Decision factor | India | Turkey | Thailand | How to use this |
|---|---|---|---|---|
| Neurosurgical depth | Large tertiary neurosurgery and oncology market with substantial city variation. | Strong private and university neurosurgery with international packages. | Bangkok has the broadest international neuro-oncology depth, with selected regional tertiary options. | Compare surgeon, navigation, neuro-ICU, pathology, radiation, and rehabilitation. |
| Cost structure | Surgery, ICU, pathology, radiation, and drugs often appear as separate items. | Packages may use TRY or foreign currency and vary in equipment assumptions. | THB estimates can exclude molecular testing, adjuvant care, ICU extension, and rehabilitation. | Request an end-to-end scenario. |
| Regional treatment | Tier 2 centers can manage selected surgery or follow-up with tertiary links. | Regional services suit selected cases after imaging review. | Regional care may be appropriate for planned cases when referral and ICU are clear. | Lesion complexity matters more than city label. |
| Continuity | Useful for South Asian, Gulf, and African patients. | Useful for Europe, Gulf, and Central Asia. | Useful for Southeast Asia and Asian routes. | Consider caregiver travel and rehabilitation after return. |
Decision guidance
A named neurosurgeon reviews the MRI, explains functional risk, lists equipment and ICU, and connects surgery to pathology, oncology, and rehabilitation.
A package promises complete removal, does not name a surgeon, omits molecular pathology or ICU, or offers no plan for weakness or seizures.
The lesion is suitable for the center’s documented expertise and complex referral, ICU, pathology, and rehabilitation links are ready.
There is a new neurologic deficit, prolonged seizure, reduced consciousness, severe headache with vomiting, or rapidly worsening behavior.
Reports for review
Prepare complete MRI source files with contrast, radiology reports, prior pathology or biopsy, symptoms, neurological examination, seizure and steroid history, medicines, blood tests, prior operations or radiation, and rehabilitation needs. Ask for a written Thailand plan naming lesion goal, operative route, navigation, monitoring, pathology, ICU, adjuvant treatment, THB validity, travel restrictions, and home handover.
Upload medical reportsSend contrast MRI source data, comparison studies, CT, PET, spine or vascular imaging, and reports with dates.
Include biopsy, frozen section, histology, molecular markers, prior slide review, and treatment implications.
Describe headaches, seizures, weakness, speech, vision, balance, cognition, behavior, and swallowing.
List surgery, radiation, chemotherapy, targeted or immune treatment, steroids, seizure medicines, and response.
Include heart, lung, kidney, clotting, infection, diabetes, nutrition, and anesthesia information.
List steroid dose, seizure medicines, anticoagulants, supplements, allergies, and recent changes.
Share passport, visa, companion, mobility, language, accessible housing, insurance, and flexible flights.
Name neurosurgeon, oncologist, neurologist, rehabilitation, emergency hospital, and caregiver.
Ask biopsy or resection, corridor, navigation, mapping, monitoring, equipment, ICU, and pathology assumptions.
Request molecular testing, radiation, chemotherapy, targeted medicine, MRI, steroids, and seizure plans.
Confirm speech, movement, cognition, swallowing, vision, caregiver, and rehabilitation support.
Agree fit-to-fly, delay, emergency, privacy, cancellation, refund, and records handover conditions.
Common questions
A selected biopsy or resection may be THB 660,000 to 1,650,000, while combined or complex neuro-oncology can reach THB 1,320,000 to 6,600,000 or more.
Usually only when the quotation names the complete adjuvant plan. Surgery, pathology, radiation, and medicines are often separate phases.
No. The team may prioritize diagnosis, decompression, or maximal safe removal when complete excision risks speech, movement, vision, cognition, or life.
Suitability depends on symptoms, pressure, seizures, swelling, treatment urgency, and airline advice. New deficits or reduced consciousness need local urgent care.
Deep, eloquent, skull-base, vascular, or brainstem lesions may need mapping, monitoring, specialized access, longer surgery, and more intensive recovery.
The final tumor type and molecular findings may lead to radiation, chemotherapy, targeted therapy, immunotherapy, surveillance, or another operation.
It depends on procedure, neurologic function, ICU course, swelling, seizures, rehabilitation, and the need for adjuvant treatment.
Only after the exact lesion, surgeon, equipment, neuro-ICU, pathology, oncology, and transfer pathway are verified.
Inpatient medicines may be included, but ongoing supply, taper supervision, monitoring, and home prescriptions must be confirmed.
Send contrast MRI source images, pathology, symptoms, seizures, steroids, medicines, prior treatment, examination, and rehabilitation needs.
Review and sources
The ranges separate a defined biopsy or resection, combined surgery and adjuvant treatment, and complex or recurrent neuro-oncology. The working conversion is approximately THB 33 per USD using the Bank of Thailand source checked in July 2026. The budget expands beyond theatre to mapping, monitoring, pathology, ICU, radiation, medicines, seizures, steroids, rehabilitation, accommodation, and home imaging. The final hospital estimate must follow source MRI and pathology review.
This page is educational and cannot diagnose a brain tumor, choose an operation, guarantee safe removal, or establish a hospital’s current authorization. A neurosurgical and neuro-oncology team should review the source imaging and pathology. New weakness, seizure, reduced consciousness, severe headache with vomiting, or confusion requires urgent local medical care.
National Cancer Institute, Thailand · Accessed 2026-07-19
Supports: Cancer service context.
National Cancer Institute, Thailand · Accessed 2026-07-19
Supports: Registry context.
King Chulalongkorn Memorial Hospital · Accessed 2026-07-19
Supports: Multidisciplinary oncology and cellular-care context.
Thailand Medical Hub, Ministry of Public Health · Accessed 2026-07-19
Supports: Medical-service context.
Thailand Medical Hub, Ministry of Public Health · Accessed 2026-07-19
Supports: Provider verification context.
Healthcare Accreditation Institute, Thailand · Accessed 2026-07-19
Supports: Quality context.
Bank of Thailand · Accessed 2026-07-19
Supports: Currency context.
Related planning
Compare a different Thailand oncology route.
Review another cancer treatment sequence.
Compare disease-specific planning.
Review drug-cycle and monitoring costs.
Understand immune-treatment planning.
Compare India city ranges.
Compare another destination.
Prepare MRI and pathology records.
Request an independent neuro-oncology review.
Plan rehabilitation and home continuity.
Questions about an estimate? Email support@virellohealth.com.